Baxter's Potential $4 Billion Deal with Carlyle Group Boosts Stock 5%
Friday, 5 July 2024, 18:08
Baxter's Stock Surge
Baxter's stock has experienced a 5% surge following reports of a potential deal.
$4 Billion Deal with Carlyle Group
The rumored deal involves a significant transaction with Carlyle Group for Baxter's kidney care unit.
Potential Sale Outcome
The deal might lead to a sale of the unit instead of the initially planned spinoff.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.